Announcements

AbCellera Biologics Inc. filed a current report on August 10, 2026, announcing positive top-line results from the Phase 2 portion of its Phase 1/2 clinical trial evaluating ABCL635, an investigational neurokinin 3 receptor antagonist antibody.

MarineMax, Inc. filed a current report on August 10, 2026, disclosing that on August 9, 2026, it entered into an Agreement and Plan of Merger with SHM Holdco, LLC and Intrepid Holdco, Inc., affiliates of Safe Harbor Marinas, LLC, a portfolio company of Blackstone …

Replimune Group, Inc. filed a current report on August 10, 2026, disclosing that on August 9, 2026, the company entered into an underwriting agreement for a public offering of common stock and pre-funded warrants, with estimated net proceeds of approximately $140.5 million.

Strategy Inc filed an 8-K current report on August 10, 2026, disclosing updates to its at-the-market offering program, bitcoin holdings, share repurchase activity, and USD Reserve balance for the period ending August 9, 2026.

Powerfleet, Inc. filed a Current Report on Form 8-K on August 10, 2026, disclosing the issuance of a press release covering financial results for the fiscal quarter ended June 30, 2026, along with a slide presentation to accompany a same-day investor conference call.

Evolv Technologies Holdings, Inc. filed a Form 8-K on August 10, 2026, disclosing that a U.S. federal court granted preliminary approval on August 6, 2026, to a settlement resolving multiple stockholder derivative actions and a pre-suit demand against the company.

Archer Aviation Inc. filed a Current Report on Form 8-K on August 10, 2026, disclosing that on August 9, 2026, it entered into a definitive Equity Purchase Agreement with The Boeing Company to acquire three aviation-related subsidiaries in an all-equity transaction.